Hemab Therapeutics Holdings, Inc. (COAG)
NASDAQ: COAG · Real-Time Price · USD
47.31
+1.48 (3.23%)
At close: Jul 24, 2026, 4:00 PM EDT
47.31
0.00 (0.00%)
After-hours: Jul 24, 2026, 4:10 PM EDT

COAG Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Jul '26 Dec '25 Dec '24
Debt / Equity Ratio
0.000.000.01
Net Debt / Equity Ratio
0.821.040.75
Net Debt / EBITDA Ratio
-2.641.73
Net Debt / FCF Ratio
-3.001.89
Quick Ratio
12.4017.3713.21
Current Ratio
12.8518.0313.95
Return on Equity (ROE)
--46.99%-55.05%
Return on Assets (ROA)
--48.01%-52.53%
Return on Invested Capital (ROIC)
--12236.57%-2698.78%
Return on Capital Employed (ROCE)
--51.24%-56.24%
SEC Filings: 10-K · 10-Q